Alexandria, Va. – Conquer Cancer®, the ASCO Foundation is pleased to announce the recipients of the 2020 Gastrointestinal Cancers Merit Awards.

These awards recognize the quality and scientific merit of research submitted by oncology fellows and trainees to an ASCO-sponsored or cosponsored meeting. The selected early-career researchers of these Conquer Cancer Merit Awards presented their findings at the 2020 Gastrointestinal Cancers Symposium in San Francisco, Calif., from January 23 – 25, 2020. 

2020 Recipients

Mohammed Al-Jumayli, MD, Kansas University Cancer Center

Limor Appelbaum, MD, Beth Israel Deaconess Medical Center

Francesca Battaglin, MD, USC Norris Comprehensive Cancer Center, Keck School of Medicine

Giacomo Bregni, MD, Institut Jules Bordet-Université Libre de Bruxelles (ULB)

Jason Henry, MD, The University of Texas MD Anderson Cancer Center 

Daniel King, MD, PhD, Stanford University

Yusuke Koseki, MD, Shizuoka Cancer Center

Jeremy D. Kratz, MD, University of Wisconsin Carbone Cancer Center

Rachel M. Lee, MD, MSPH, Winship Cancer Institute, Emory University

Michael Lee, MBChB, FRACP, BC Cancer

Ashley Matusz-Fisher, MD, Carolinas Medical Center

Amir Mehrvarz Sarshekeh, MD, The University of Texas MD Anderson Cancer Center

Shehara Ramyalini Mendis, MBBS, FRACP, BC Cancer

Kanika Gupta Nair, MD, Cleveland Clinic Foundation

Oliver Peacock, PhD, The University of Texas MD Anderson Cancer Center

Ibrahim Halil Sahin, MD, Winship Cancer Institute, Emory University

Anthony Joseph Scholer, BS, MD, MS, John Wayne Cancer Institute at Providence St. John’s Health Center

Victoria Serpas, MD, The University of Texas MD Anderson Cancer Center

Elaine Tan, MD, University of South Florida

Michael K. Turgeon, MD, Winship Cancer Institute, Emory University

Irene S. Yu, MD, BC Cancer

Gemma Zucchelli, MD, Azienda Ospedaliera Universitaria Pisana

 

The 2020 Gastrointestinal Cancers Merit Awards are supported by:

Anonymous, AbbVie, Inc., ASCO Employees, Association of Northern California Oncologists, AstraZeneca, Friends and Family of Dr. and Mrs. Ronald Beller, Dr. and Mrs. Douglas W. Blayney, Breast Cancer Research Foundation®, Bristol-Myers Squibb, Jonathan K. and Cora Y. Cho Charitable Fund, Eisai Inc., Estate of Darla C. Ellis, Epiphany Partners Inc., GlaxoSmithKline Oncology, Harborside, Ipsen Biopharmaceuticals Inc., Kimberly Irvine, Michael Kelley, MD & Elise Hoffman, PharmD, William T. Leslie, MD, Lilly, Loxo Oncology Inc., a wholly owned subsidiary of Eli Lilly and Company, Gary H. Lyman, MD, MPH, FASCO and Nicole M. Kuderer, MD, Therese Marie Mulvey, MD, FASCO, Friends and Family of Dr. James B. Nachman, New Rhein Healthcare, Northern New England Clinical Oncology Society, Dr. Kathleen Pritchard Medicine Professional Corporation, Sarah Cannon Research Institute, Frances A. Shepherd, MD, FASCO, Stephen A. Sherwin, MD, Drs. Rachna and Puneet Shroff, Mr. Jackson G. Simpson, Syndax Pharmaceuticals, Inc., Nizar M. Tannir, MD, Anthony and Marilyn Tolcher, and Dr. Michael and Deborah Troner.